NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective

Biochemical and Biophysical Research Communications

Volumn 469, Issue 4, 2016, Pages 1012-1020

  Sandanger, Ø ^a,b   Gao, E ^c   Ranheim, T ^a,b   Bliksoen M ^b,d   Kaasboll O J ^b,e   Alfsnes, K ^a,b   Nymo, Ståle H ^a,b   Rashidi, A ^a,b   Ohm, I K ^a,b   Attramadal, Håvard ^b   Aukrust, P ^a,b,d,e   Vinge, L E ^a,b   Yndestad, A ^a,b,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ASC; Heart; Inflammasome; Ischemia reperfusion; NLRP3

Indexed keywords

CRYOPYRIN; INFLAMMASOME; MESSENGER RNA; PROTEIN KINASE B; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; CYTOKINE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVATION; FEMALE; GENOTYPE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; LEFT CORONARY ARTERY; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE INJURY; ANIMAL; C57BL MOUSE; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MOUSE; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; CARRIER PROTEINS; CYTOKINES; FEMALE; IMMUNITY, INNATE; INFLAMMASOMES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY;

EID: 84957849310     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.12.051     Document Type: Article

References (32)

1. C.P. Baines How and when do myocytes die during ischemia and reperfusion: the late phase J. Cardiovasc Pharmacol. Ther. 16 2011 239 243
2. R. Garg, A. Tellez, C. Alviar, and et al. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment Catheter Cardiovasc Interv. 72 2008 205 209
3. G. Vilahur, and L. Badimon Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor Front. Physiol. 5 2014 496
4. N.B. Bryan, A. Dorfleutner, Y. Rojanasakul, and et al. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain J. Immunol. 182 2009 3173 3182
5. F.G. Bauernfeind, G. Horvath, A. Stutz, and et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression J. Immunol. 183 2009 787 791
6. O. Sandanger, T. Ranheim, L.E. Vinge, and et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury Cardiovasc Res. 99 2013 164 174
7. B.F. Py, M.S. Kim, H. Vakifahmetoglu-Norberg, and et al. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity Mol. Cell 49 2013 331 338
8. H. Hara, K. Tsuchiya, I. Kawamura, and et al. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity Nat. Immunol. 14 2013 1247 1255
9. R. Munoz-Planillo, P. Kuffa, G. Martinez-Colon, and et al. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter Immunity 38 2013 1142 1153
10. F. Martinon Signaling by ROS drives inflammasome activation Eur. J. Immunol. 40 2010 616 619
11. C.A. Dinarello A clinical perspective of IL-1beta as the gatekeeper of inflammation Eur. J. Immunol. 41 2011 1203 1217
12. M. Kawaguchi, M. Takahashi, T. Hata, and et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury Circulation 123 2011 594 604
13. Y. Liu, K. Lian, L. Zhang, and et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury Basic Res. Cardiol. 109 2014 415
14. C. Marchetti, J. Chojnacki, S. Toldo, and et al. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse J. Cardiovasc Pharmacol. 63 2014 316 322
15. W.M. Jong, J.C. Leemans, N.C. Weber, and et al. Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression Int. J. Cardiol. 177 2014 41 43
16. O.N. Kanneganti TD, M. Body-Malapel, A. Amer, J.H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, P. Vandenabeele, J. Bertin, A. Coyle, E.P. Grant, S. Akira, and G. Núñez Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 Nature 2006 233 236
17. M.J.N. Ozören, L. Franchi, T.D. Kanneganti, M. Body-Malapel, I. Ertürk, R. Jagirdar, L. Zhu, N. Inohara, J. Bertin, A. Coyle, E.P. Grant, and G. Núñez Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18 secretion in response to Listeria monocytogenes J. Immunol. 2006 4337 4342
18. E. Gao, Y.H. Lei, X. Shang, and et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse Circ. Res. 107 2010 1445 1453
19. T. Ha, Y. Hu, L. Liu, and et al. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism Cardiovasc Res. 87 2010 694 703
20. Z.V. Schofield, T.M. Woodruff, R. Halai, and et al. Neutrophils-a key component of ischemia-reperfusion injury Shock 40 2013 463 470
21. G. Zhao, S. Wang, Z. Wang, and et al. CXCR6 deficiency ameliorated myocardial ischemia/reperfusion injury by inhibiting infiltration of monocytes and IFN-gamma-dependent autophagy Int. J. Cardiol. 168 2013 853 862
22. C.J. Zuurbier, W.M. Jong, O. Eerbeek, and et al. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling PLoS One 7 2012 e40643
23. J.W. Dong, J.G. Vallejo, H.P. Tzeng, and et al. Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways Am. J. Physiol. Heart Circ. Physiol. 298 2010 H1079 H1087
24. Y. Xiang, X. Wang, C. Yan, and et al. Adenosine-5'-triphosphate (ATP) protects mice against bacterial infection by activation of the NLRP3 inflammasome PLoS One 8 2013 e63759
25. E.M. Weinheimer-Haus, R.E. Mirza, and T.J. Koh Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing PLoS One 10 2015 e0119106
26. K. Mao, S. Chen, M. Chen, and et al. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock Cell Res. 23 2013 201 212
27. H.D. Jones, T.R. Crother, R.A. Gonzalez-Villalobos, and et al. The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury Am. J. Respir. Cell Mol. Biol. 50 2014 270 280
28. S.S. Iyer, W.P. Pulskens, J.J. Sadler, and et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome Proc. Natl. Acad. Sci. U. S. A. 106 2009 20388 20393
29. H. Huang, H.W. Chen, J. Evankovich, and et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury J. Immunol. 191 2013 2665 2679
30. S. Lecour Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? J. Mol. Cell Cardiol. 47 2009 32 40
31. H. Tong, K. Imahashi, C. Steenbergen, and et al. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective Circ. Res. 90 2002 377 379
32. M. Lamkanfi, J.L. Mueller, A.C. Vitari, and et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome J. Cell Biol. 187 2009 61 70